Journey to hypofractionation in radiotherapy for breast cancer: critical reviews for recent updates
Radiation Oncology Journal · 31.12.2022 · 40 (4) · 216-224
DOI: 10.3857/roj.2022.00577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiation Oncology Journal, erschienen am 31.12.2022. Verfasst von Nalee Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Historical conventional fractionated radiation therapy (RT) for breast cancer consisted of 1.8–2.0 Gy per fraction with a total dose of 45–60 Gy over 5–7 weeks. Based on radiobiological characteristics, a low α/β is suspected of breast cancer resulting in sensitivity to higher dose per fraction (2.5–3.0 Gy). Over the past 10 years, multiple clinical trials support the application of shorter treatment regimen with hypofractionated RT (HypoRT). Recently, ultra-HypoRT with 5 fractions showed favorable outcomes. Although the safety and efficacy of HypoRT has been supported by high-quality randomized trials, there are still some worries and doubts around HypoRT from radiation oncologists. However, the radiation oncology community have now reached an important timepoint for adopting HypoRT during the COVID-19 pandemic. The aim of this review is to provide an overview of HypoRT in breast cancer based on prospective randomized trials and discuss the special consideration regarding HypoRT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Zitieren
APA
Kim, N., & Kim, Y. B. (2022). Journey to hypofractionation in radiotherapy for breast cancer: critical reviews for recent updates. Radiation Oncology Journal, 40(4), 216-224. https://doi.org/10.3857/roj.2022.00577
Vancouver
Kim N, Kim YB. Journey to hypofractionation in radiotherapy for breast cancer: critical reviews for recent updates. Radiation Oncology Journal. 2022;40(4):216-224. doi:10.3857/roj.2022.00577
BibTeX
@article{Kim2022,
author = {Kim, Nalee and Kim, Yong Bae},
title = {Journey to hypofractionation in radiotherapy for breast cancer: critical reviews for recent updates},
journal = {Radiation Oncology Journal},
year = {2022},
volume = {40},
number = {4},
pages = {216--224},
doi = {10.3857/roj.2022.00577}
}
EUVIMED